Metastatic prostate cancer Trials in Madrid, Spain
Conditions / Metastatic prostate cancer / Madrid, Spain
Metastatic prostate cancer is a medical condition with active clinical research programs worldwide.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01957436 | A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05933876 | The Impact of Radiotherapy on Oligometastatic Cancer | RECRUITING | — |
| NCT03072238 | Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT04179864 | A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer | TERMINATED | PHASE1/PHASE2 |
| NCT04887506 | TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer | COMPLETED | PHASE3 |
| NCT07181161 | Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer | RECRUITING | PHASE1/PHASE2 |
| NCT03871816 | A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer | COMPLETED | — |
| NCT05413421 | Study of ORIC-944 in Patients With Metastatic Prostate Cancer | RECRUITING | PHASE1 |
| NCT04446117 | Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02066961 | A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer | COMPLETED | — |